Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
81.77
-0.06 (-0.07%)
At close: Dec 5, 2025, 4:00 PM EST
81.76
-0.01 (-0.01%)
After-hours: Dec 5, 2025, 6:05 PM EST
Tarsus Pharmaceuticals Revenue
Tarsus Pharmaceuticals had revenue of $118.70M in the quarter ending September 30, 2025, with 146.68% growth. This brings the company's revenue in the last twelve months to $366.10M, up 182.44% year-over-year. In the year 2024, Tarsus Pharmaceuticals had annual revenue of $182.95M with 948.62% growth.
Revenue (ttm)
$366.10M
Revenue Growth
+182.44%
P/S Ratio
9.10
Revenue / Employee
$1,133,437
Employees
323
Market Cap
3.47B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TARS News
- 16 days ago - Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 - Seeking Alpha
- 4 weeks ago - Tarsus Pharmaceuticals, Inc. (TARS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements - GlobeNewsWire
- 5 weeks ago - Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewsWire
- 2 months ago - Tarsus Pharmaceuticals: Considering If The Big Marketing Push Will Pay Off - Seeking Alpha
- 3 months ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Top 2 Health Care Stocks That May Fall Off A Cliff In August - Benzinga
- 4 months ago - Tarsus Pharmaceuticals, Inc. (TARS) Q2 2025 Earnings Call Transcript - Seeking Alpha